FINWIRES · TerminalLIVE
FINWIRES

Trump Says Iran Weak Beyond Waterway Pressure as Vance Heads to Islamabad for Key Talks

-- US President Donald Trump on Friday said Iran lacks leverage beyond short-term pressure via global waterways, stressing negotiations as its only viable path.

Trump said in a Truth Social post, "The Iranians don't seem to realize they have no cards, other than a short term extortion of the World by using international waterways. The only reason they are alive today is to negotiate!"

On Friday, Trump told the New York Post in an interview that a decision on Iran talks is expected within about 24 hours, signaling a critical window for a potential agreement.

"We're going to find out in about 24 hours," Trump reportedly said when asked about the likelihood of successful negotiations.

He added that the US is rearming ships with "the best ammunition" and more advanced weapons than previously deployed, adding that the military is in a stronger position than in earlier operations.

Trump said if no agreement is reached, the US will use those capabilities, warning any action would be carried out "very effectively."

has reached out to the White House for any comments.

Ahead of the US-Iran talks in Islamabad, oil prices held near Thursday's levels, with West Texas Intermediate rising 0.34% to $98.20 per barrel and Brent up 0.80% to $96.69/bbl, while Murban fell 1.66% to $97.97/bbl.

Related Articles

Research

Research Alert: CFRA Maintains Buy Rating On Shares Of Quest Diagnostics

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our 12-month price target at $235. This is based on a forward P/E of 21.9x our 2026 EPS estimate, a premium to DGX's three-year forward average of 16.8x due to our view of strengthening sales and earnings growth, backed by higher health care utilization trends and some regulatory relief due to postponement of lab reimbursement cuts until at least 2027. We think lab testing providers remain a relatively well-positioned area within health care given lower policy risks, supportive testing demand, and attractive earnings growth potential. On a compounded annual basis from 2025-2028, we expect near 8% EPS growth, raising our 2026 EPS to $10.73 from $10.60 and 2027 EPS to $11.50 from $11.42. We also anticipate additional smaller M&A opportunities, along with healthy dividend increases (recent 7.5% boost; shares yield 1.7%) as cash flow generation remains supportive over the near term.

$DGX
Research

Research Alert: Pega: Q1 Results Miss, But Strength In Pega Cloud Offsets

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:PEGA reported total revenue of $430M, missing consensus by $37.2M and declining 10% Y/Y, while non-GAAP EPS of $0.46 missed by $0.23 and fell 39% Y/Y. However, Pega Cloud revenue surged 36% Y/Y to $205M, now representing 47.7% of total revenue and validating the cloud transition thesis. Pega Cloud annual contract value (ACV) acceleration remains the standout metric, growing 29% Y/Y to $906.7M and accelerating from 23% growth in Q1, demonstrating continued strong demand for the company's AI workflow automation platform. Total ACV grew 12% Y/Y to $1.62B, with backlog increasing 16% Y/Y to $2.01B providing revenue visibility. We believe the robust cash flow generation of $206.5M in free cash flow and a solid balance sheet with $474M in cash provides financial flexibility for continued AI investment. Despite near-term profitability pressure, we expect the sustained Pega Cloud momentum and strong ACV growth to support the business transformation.

$PEGA
Asia

Air New Zealand CFO to Resign

Air New Zealand (ASX:AIZ, NZE:AIR) said that Chief Financial Officer Richard Thomson has resigned, effective Aug. 28, according to a Wednesday filing with the New Zealand bourse.The airline has started the process of searching for a new CFO, the filing added.

$ASX:AIZ$NZE:AIR